ORCHESTRA

A Double-Blind, Placebo-Controlled, Randomized, 18-Month Phase 2a Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Oral UCB0599 in Study Participants With Early Parkinson's Disease

Topic / Pathology

  • Parkinson's Disease

Objectives

To have more informations, click on the link below:

Clinical Trials Register

Sponsor

UCB

Status

Recruitment completed

Participating centers

Share

Updated on 17 February 2023